A New COVID-19 Vaccine Prototype Deemed Promising After Showing a 94.5% Efficency

A New COVID-19 Vaccine Prototype Deemed Promising After Showing a 94.5% Efficency

Moderna announced this Monday that their experimental COVID-19 vaccine which has been tested out on close to 30,000 patients throughout the U.S, has demonstrated a 94.5% efficiency rate in preventing the virus. Centex Studies in McAllen is one of the laboratories that is conducting the study among Hispanic volunteers.

 

Special Reports